access

News

Celebrations as NHS England agrees deal for Vertex’ cystic f...

NHS England has agreed a deal with Vertex for its three-drug cystic fibrosis therapy Kaftrio, just days after the EMA’s human medicines committee recommended approval of the dr

News

As CHMP backs Vertex’ CF triple, campaigners plead for speed...

Cystic fibrosis patient groups in the UK are celebrating a recommendation by the EMA’s human medicines committee to approve Vertex' three-drug therapy Kaftrio – but fear anothe

Views & Analysis

Talking vaccines: Industry’s role in protecting the Gavi gen...

A new report highlights the important work of companies across the industry in boosting access to vaccines worldwide – and warns of the challenges ahead.

Views & Analysis

On the pulse of ASCO: pricing and clinical trial access

New survey data from MedPanel, compiled exclusively for pharmaphorum, has revealed US physicians’ thoughts on the topics set to dominate ASCO.

News

Many patients still denied cancer drugs in UK, survey finds

The Institute for Cancer Research has called for action to improve access to innovative cancer treatments after a new survey found that many UK patients are being denied drugs and see the p

Views & Analysis